(Q45958411)

18 December 2017

title

Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. (English)

1 reference

18 December 2017

rhinocerebral mucormycosis

main subject

1 reference

A Ramos

1

1 reference

18 December 2017

V Cuervas-Mons

2

1 reference

18 December 2017

A Noblejas

3

1 reference

18 December 2017

I Baños

4

1 reference

18 December 2017

P Duran

5

1 reference

18 December 2017

R Marcos

6

1 reference

18 December 2017

V Sánchez-Turrión

7

1 reference

18 December 2017

M Jiménez

8

1 reference

18 December 2017

B Arellano

9

1 reference

18 December 2017

C Corbacho

10

1 reference

18 December 2017

I Sánchez-Romero

11

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

18 December 2017

Transplantation Proceedings

published in

1 reference

18 December 2017

volume

41

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

1972-1975

1 reference

18 December 2017

Zygomycetes in human disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Efficacy and safety of caspofungin in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Successful treatment of rhinomaxillary form of mucormycosis infection after liver transplantation: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Fungal infections in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Recent advances in antifungal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Invasive zygomycosis in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Successful treatment of mucor infection after liver or pancreas-kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Mucormycosis of the nose and paranasal sinuses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Fungaemia due to Fusarium spp. in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Invasive infections due to Clavispora lusitaniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Prophylaxis of invasive mycoses in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Development of candidemia on caspofungin therapy: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Low-dose amphotericin for prevention of serious fungal infection following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

Posaconazole as salvage therapy for zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.01.077

10.1016/J.TRANSPROCEED.2009.01.077

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017